NCT01991327View on ClinicalTrials.gov

Assessment of Drug-Drug Interactions of Androxal With Cytochrome P450 Isoenyzmes in Healthy Males

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Drug-drug Interaction
Interventions
DRUG

Androxal

DRUG

Placebo

Trial Locations (1)

33014

Miami

All Listed Sponsors
lead

Repros Therapeutics Inc.

INDUSTRY

NCT01991327 - Assessment of Drug-Drug Interactions of Androxal With Cytochrome P450 Isoenyzmes in Healthy Males | Biotech Hunter | Biotech Hunter